Synthesis 2003(18): 2844-2850  
DOI: 10.1055/s-2003-42442
PAPER
© Georg Thieme Verlag Stuttgart · New York

Formation of Two 4-Imidazolylmethylphosphonium Salts and their Synthetic Studies Toward Histamine H3-Ligands

Shinya Harusawaa, Makoto Kawamuraa, Shuji Koyabua, Tomoko Hosokawaa, Lisa Arakia, Yasuhiko Sakamotob, Takeshi Hashimotoc, Yumiko Yamamotoc, Atsushi Yamatodanic, Takushi Kurihara*a
a Osaka University of Pharmaceutical Sciences, 4-20-1, Nasahara, Takatsuki, Osaka 569-1094, Japan
Fax: +81(72)6901086; e-Mail: kurihara@gly.oups.ac.jp;
b R&D Division, AZWELL, Inc., 2-24-3, Sho, Ibaraki, Osaka 567-0806, Japan
Fax: +81(72)6224999; e-Mail: ya-sakamoto@azwell.co.jp;
c Graduate School of Allied Health Sciences, Faculty of Medicine, Osaka University, Osaka 565-0871, Japan
Fax: +81(6)68792562; e-Mail: yamatoda@sahs.med.osaka-u.ac.jp;
Further Information

Publication History

Received 25 August 2003
Publication Date:
21 October 2003 (online)

Abstract

A simple and convenient preparation of {[1H-imidazol-4(5)-yl]methyl}triphenylphosphonium chloride (5) is described. The phosphonium salt 5 could be applied to the synthesis of 1-[1H-imidazol-4(5)-yl]-5-arylpentan- or 6-arylhexan-3-ones 4a-d exhibiting histamine H3-antagonistic activities via a 1,3-diazafulvene intermediate 6 generated from 5. Further, two-methylene-enlongated homolog 3 of imifuramine was efficiently synthesized, starting from Wittig olefination of aldehyde 24 using [(1-tritylimidazol-4-yl)methyl]triphenylphosphonium chloride 7.

    References

  • 1 Grimmett MR. In Comprehensive Heterocyclic Chemistry II: Imidazoles   Vol. 3:  Katritzky AR. Rees CW. Scriven EF. Pergamon; Oxford: 1996.  p.77-220  
  • For reviews, see:
  • 2a Stark H. Schlicker E. Schunack W. Drugs Future  1996,  21:  507 
  • 2b Leurs R. Blandian P. Tedford C. Timmerman H. TIPS  1998,  19:  177 
  • 2c Watanabe T. Timmerman H. Yanai K. Histamine Reseach in the New Millennium   Elsevier; Amsterdom: 2001. 
  • 3 For a review, see: Hough LB. Mol. Pharmacol.  2001,  59:  415 
  • 4a Harusawa S. Imazu T. Takashima S. Araki L. Ohishi H. Kurihara T. Yamamoto Y. Yamatodani A. Tetrahedron Lett.  1999,  40:  2561 
  • 4b Harusawa S. Imazu T. Takashima S. Araki L. Ohishi H. Kurihara T. Sakamoto Y. Yamamoto Y. Yamatodani A. J. Org. Chem.  1999,  64:  8608 
  • 5 Hashimoto T. Harusawa S. Araki L. Zuiderveld OP. Smit MJ. Imazu T. Takashima S. Yamamoto Y. Sakamoto Y. Kurihara T. Leurs R. Bakker R. Yamatodani A. J. Med. Chem.  2003,  46:  3162 
  • 6a Vollinga RC. Menge WMPB. Leurs R. Timmerman H. J. Med. Chem.  1995,  38:  266 
  • 6b Vollinga RC. Menge WMPB. Leurs R. Timmerman H. J. Med. Chem.  1995,  38:  2244 
  • 6c De Esch IJP. Gaffar A. Menge WMPB. Timmerman H. Bioorg. Med. Chem.  1999,  7:  3003 
  • 6d Kazuta Y. Hirano K. Natsume K. Yamada S. Kimura R. Matsumoto S. Furuichi K. Matsuda A. Shuto S. J. Med. Chem.  2003,  46:  1980 
  • 7 Harusawa S. Koyabu S. Inoue Y. Sakamoto Y. Araki L. Kurihara T. Synthesis  2002,  1072 
  • 8a Lassalle G, Purcell T, Galtier D, Williams PH, and Galli F. inventors; Eur. Pat. Appl., EP  565396. 
  • 8b Perard S, Zard L, and Rossey G. inventors; Eur. Pat. Appl., EP  614986. 
  • 8c Lassalle G, Galtier D, and Galli F. inventors; Eur. Pat. Appl., EP  643047. 
  • 8d Galtier D, and Lassalle G. inventors; Eur. Pat. Appl., EP  643046. 
  • 8e Lassalle G, Galtier D, and Galli F. inventors; Fr Demande., FR  2710067. 
  • 8f Lassalle G, Purcell T, Galtier D, Williams PH, and Galli F. inventors; US Pat., US  5453430. 
  • 8g Yokohama S, Takeda Y, Kawakoshi K, and Yamamoto K. inventors; Jpn. Kokai Tokkyo Koho, JP  11279156. 
  • 9a Bruice TC. Herz JL. J. Am. Chem. Soc.  1964,  86:  4109 
  • 9b Harusawa S. Murai Y. Moriyama H. Imazu T. Ohishi H. Yoneda R. Kurihara T. J. Org. Chem.  1996,  61:  4405 
  • 10a Coates IH, Charles NP, and William OA. inventors; Eur. Pat. Appl., EP  306323. 
  • 10b Cordi AA. Snyers MP. Giraud-Mangin D. Van der Maesen C. Van Hoeck JP. Beuze S. Ellens E. Napora F. Gillet CL. Gorissen H. Calderon P. Remacle MD. Janssens de Varebeke P. Van Dorsser W. Roba J. Eur. J. Med. Chem.  1990,  25:  557 
  • 11a Zbiral E. Hugl E. Phosphorus  1972,  2:  29 
  • 11b Zbiral E. Synthesis  1974,  775 
  • 11c Webb RL. Lewis JJ. J. Heterocycl. Chem.  1981,  18:  1301 
  • 12a Staab HA. Datta AP. Angew. Chem., Int. Ed. Engl.  1964,  3:  132 
  • 12b Devos A. Remion J. Frisque-Hesbain AM. Colens A. Ghosez L. J. Chem. Soc., Chem. Commun.  1979,  1180 
  • 12c Villeneuve GB. Chan TH. Tetrahedron Lett.  1997,  38:  6489 
  • 13 Chaturvedi N. Goodman M. Bowers C. Int. J. Peptide Protein Res.  1981,  17:  72 
  • 14 Huckin SN. Weiler L. J. Am. Chem. Soc.  1974,  96:  1082 
  • 15a Vollinger RC. Zuiderveld OP. Scheerens H. Bast A. Timmerman H. Methods Find Exp. Clin. Pharmacol.  1992,  14:  747 
  • 15b Hashimoto T. Hidaka R. Yamamoto Y. Harusawa S. Araki L. Kurihara T. Sakamoto Y. Yamatodani A. Inflamm. Res.  2003,  in press 
  • 16 Koert U. Stein M. Wagner H. Liebings Ann.  1995,  1415 
  • 18a Frigerio M. Santagostino M. Sputore S. Palmisano G. J. Org. Chem.  1995,  60:  7272 
  • 18b Frigerio M. Santagostino M. Tetrahedron. Lett.  1994,  35:  8019 
  • 18c Dess DB. Martin JC. J. Am. Chem. Soc.  1991,  113:  7277 
  • 19 Bonnet B. Soullez D. Girault S. Maes L. Landry V. Davioud-Charvet E. Sergheraert C. Bioorg. Med. Chem.  2000,  8:  95 
17

Dess-Martin periodinane was purchased from Lancaster or Aldrich.